Conventus Orthopaedics, Inc.
https://www.conventusortho.com/
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From Conventus Orthopaedics, Inc.
Targeting Solid Cancers With CAR-T: Japan’s Noile-Immune Looks To Partner Platform
Setting a strategic focus on solid cancers with its enhanced PRIME CAR-T technology, Koji Tamada, CEO of Noile-Immune, shared the Japanese bioventure's collaboration strategies and views on the next generation of cell therapies.
Medtech Execs On The Move, February 2016
Recent executive-level company changes and promotions in the medical device and diagnostics industries.
De-Risking China For Foreign Life Science Investors
With $1 billion under management, Hong Kong-based private equity firm Ally Bridge Group bagged multiple deals in 2015 including WuXi's $3.3 billion privatization. ABG's CEO Frank Yu talks about pursuing a holistic approach that goes beyond ABG's China roots.
INTERVIEW: Ally Bridge CEO On De-Risking China And Investing In 2016
With $1bn under management, the Hong Kong private equity firm Ally Bridge Group bagged multiple deals in 2015 including WuXi's $3.3bn privatization. CEO Frank Yu spoke to PharmAsia News about pursuing a holistic approach that goes beyond its China roots.
Company Information
- Industry
-
Medical Devices
- Implantable Devices
-
Surgical Equipment & Devices
- Minimally or Less Invasive
- Other Names / Subsidiaries
-
- Conventus Flower Orthopedics
- Flower Orthopedics Corporation
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice